Biotechnology Assets, S.A. (BME:BST)
Spain
· Delayed Price · Currency is EUR 0.3650
-0.0060 (-1.62%)
Jun 27, 2025, 5:35 PM CET
Biotechnology Assets Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -2.92 | 1.57 | -1.94 | -3.01 | -8.61 | Upgrade
|
Depreciation & Amortization | 1 | 1.01 | 1.03 | 1.03 | 1.04 | Upgrade
|
Other Amortization | 1.21 | 1.45 | 1.12 | 1 | 1.17 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.52 | 0.05 | - | 0.06 | 1.66 | Upgrade
|
Other Operating Activities | 0.44 | -3.57 | -0.07 | -0.08 | 8.16 | Upgrade
|
Change in Accounts Receivable | -0.46 | -1.02 | 0.37 | 0.06 | 13.12 | Upgrade
|
Change in Inventory | - | - | - | 0.02 | 8.01 | Upgrade
|
Change in Accounts Payable | 0.16 | 0.06 | -0.52 | -0.76 | -10.26 | Upgrade
|
Change in Other Net Operating Assets | -0.03 | 0.47 | - | 0.18 | 1.41 | Upgrade
|
Operating Cash Flow | -0.07 | 0.05 | -0.02 | -1.5 | 8.81 | Upgrade
|
Capital Expenditures | -0.01 | -0.07 | -0.13 | -0.02 | -0 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | 44.84 | Upgrade
|
Sale (Purchase) of Intangibles | -0.71 | -0.26 | -1.99 | -0.64 | -0.39 | Upgrade
|
Investment in Securities | - | - | - | - | 0.39 | Upgrade
|
Investing Cash Flow | -0.72 | -0.33 | -2.12 | -0.66 | 44.84 | Upgrade
|
Short-Term Debt Issued | 0.04 | - | - | 0.07 | - | Upgrade
|
Long-Term Debt Issued | 1.52 | 0.59 | 0.59 | 0.73 | - | Upgrade
|
Total Debt Issued | 1.56 | 0.59 | 0.59 | 0.8 | - | Upgrade
|
Short-Term Debt Repaid | - | -0.13 | -0.22 | - | -43.36 | Upgrade
|
Long-Term Debt Repaid | -1.65 | -0.59 | -0.59 | -0.56 | -14.56 | Upgrade
|
Total Debt Repaid | -1.65 | -0.72 | -0.81 | -0.56 | -57.93 | Upgrade
|
Net Debt Issued (Repaid) | -0.09 | -0.13 | -0.22 | 0.24 | -57.93 | Upgrade
|
Issuance of Common Stock | 0.9 | 0.51 | 1.51 | 3.01 | - | Upgrade
|
Repurchase of Common Stock | -0.12 | -0.08 | -0.08 | -0.01 | - | Upgrade
|
Other Financing Activities | -0.05 | -0.37 | -0.06 | 0.05 | 0.07 | Upgrade
|
Financing Cash Flow | 0.64 | -0.06 | 1.15 | 3.28 | -57.86 | Upgrade
|
Net Cash Flow | -0.16 | -0.34 | -0.99 | 1.12 | -4.21 | Upgrade
|
Free Cash Flow | -0.09 | -0.02 | -0.14 | -1.52 | 8.8 | Upgrade
|
Free Cash Flow Margin | -2.96% | -0.56% | -4.90% | -46.29% | 304.47% | Upgrade
|
Free Cash Flow Per Share | -0.00 | - | -0.00 | -0.03 | 0.23 | Upgrade
|
Cash Interest Paid | 0.13 | 0.07 | 0.13 | 0.53 | 0.18 | Upgrade
|
Cash Income Tax Paid | - | - | 0.02 | 0.11 | 0.02 | Upgrade
|
Levered Free Cash Flow | 0.35 | 2.5 | -0.97 | -1.77 | 9.87 | Upgrade
|
Unlevered Free Cash Flow | 0.46 | 2.69 | -0.76 | -1.24 | 10.08 | Upgrade
|
Change in Net Working Capital | -0.41 | 1.14 | -0.29 | 1.31 | -9.01 | Upgrade
|
Updated Oct 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.